Label: information for the user

Inaspir 25 micrograms/inhalation, suspension for inhalation in pressurized container

salmeterol (xinafoate)

Read this label carefully before starting to use this medication, as it contains important information for you.

• Keep this label, as you may need to refer to it again.

• If you have any questions, consult your doctor or pharmacist.

• This medication has been prescribed only for you, and you should not give it to others who have the same symptoms as you, as it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this label. See section 4.

Inaspir belongs to a group of medications known as bronchodilators.

Inaspir is indicated for the regular long-term treatment of reversible airway obstruction caused by asthma and chronic bronchitis (COPD). In asthma, it will be administered in combination with long-term anti-inflammatory therapy with inhaled or oral glucocorticoids.

No use Inaspir

• if you are allergic to salmeterol or any of the other ingredients in this medication (listed in section 6).

Warnings and Precautions

Consult your doctor or pharmacist before starting to use Inaspir:

• If you have ever had to stop taking any other medication for your condition due to allergy or other reasons.
• If you are being treated for any thyroid disorder.
• If you are being treated for high blood pressure.
• If you are being treated for heart problems.
• If you have diabetes mellitus.
• If you are prone to low levels of potassium in the blood.
• If you are being treated with ketoconazole (a medication used to treat fungal infections).

If you are using Inaspir for the treatment of your asthma, your doctor will want to see you regularly to check your symptoms. Go to your doctor immediately if:

• Your asthma worsens.
• You have greater difficulty breathing.
• You notice more wheezing.
• You experience more frequent feelings of choking.
• You need to use your rescue medication more frequently.

If any of the above situations occur, do not increase the number of Inaspir applications (your respiratory condition may worsen and you may become seriously ill). Go to your doctor as it may be necessary to change your asthma medication.

Patients who have been previously treated with Inaspir should be aware that it no longer contains chlorofluorocarbon (CFC) propellants for aerosols. It should be used exactly as instructed by your doctor. Your doctor may change your dosage regimen.

The active ingredient in Inaspir without CFCs is exactly the same as that in the previous Inaspir with CFCs. The only differences you may notice are the taste and the sensation of the spray in your mouth, as well as the sound of the inhaler during use. This is due to the change of propellant to eliminate the CFCs. This modification does not affect the mechanism of action of the medication. Inaspir without CFCs can be used in the same way as the previous one.

Other Medications and Inaspir

Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.

Important Information about Some of the Components of Inaspir

Use in Athletes: This medication contains salmeterol, which may produce a positive result in doping control tests.

Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Remember to use your medication. IT IS VERY IMPORTANT THAT YOU USE IT REGULARLY EVERY DAY. This will help you stay free of symptoms throughout the day and at night.

Your doctor will indicate the duration of your treatment with Inaspir. Do not suspend treatment before, even if you feel better, unless your doctor tells you to.

Inaspir should only be used by inhalation and should not be used in children under 4 years old.

If you have been prescribed Inaspir for your asthma, you must continue using any other medication you are taking to control your asthma. These should include an inhaled corticosteroid or tablets. Continue taking the same doses as before, unless your doctor tells you otherwise. Do this even if you feel better. Do not stop taking your inhaled corticosteroid (or tablets) when you start using Inaspir.

It is very important that you follow your doctor's instructions on the number of times and how often you should use Inaspir. The usage instructions are given below. If you have difficulties or do not understand the instructions, ask your doctor or pharmacist.

The recommended dose is:

Adults

• Two inhalations (50 micrograms) twice a day. If your doctor advises you, you can increase this dose to four inhalations (100 micrograms) twice a day.

Use in children and adolescents

• Children over 4 years old: two inhalations (50 micrograms) twice a day.

If you estimate that the action of Inaspir is too strong or too weak, inform your doctor or pharmacist.

Usage instructions:

Before using the inhaler for the first time or if it has not been used for a week or more, remove the mouthpiece protector by pressing it gently on both sides, shake the inhaler well, and release two puffs into the air to ensure the inhaler is functioning properly.

Using the inhaler:

1. Remove the mouthpiece protector by pressing it gently on both sides.

1. Check that there are no foreign particles inside and outside the inhaler, including the mouthpiece.

1. Shake the inhaler well to ensure the removal of any foreign particles and that the contents of the inhaler are mixed properly.

1. Hold the inhaler in a vertical position between the index and middle fingers, placing the thumb on the base, below the mouthpiece.

1. Breathe in as much air as possible and then insert the mouthpiece into the mouth, between the teeth, closing the lips over the device, but not biting it.

1. Immediately after starting to breathe in through the mouth, press the top of the inhaler to release the medication and continue breathing in deeply and constantly.

1. Hold your breath and remove the inhaler from the mouth, releasing the finger from the top of the inhaler. Continue holding your breath as long as possible.

1. If you are to administer another inhalation, hold the inhaler in a vertical position and wait for approximately half a minute before repeating steps 3 to 7.

1. Replace the mouthpiece protector by pushing it firmly and adjusting it until you hear a click.

Important

Do not perform steps 5, 6, and 7 quickly. It is essential to start breathing in as slowly as possible, just before pressing the inhaler.

Practice in front of a mirror during the first times. If you notice a "kind of fog" coming out of the top of the inhaler or from the sides of the mouth, start again from step 2.

Patients who find difficulty in coordinating the handling of the inhaler with inhalation may use an appropriate inhalation chamber (BABYHALER, inhalation chamber for children up to 5 years old).

Small children may need help, with their parents handling the inhaler for them. Encourage the child to breathe in and handle the inhaler just after the child starts breathing in. Practice together the technique. Older children or people with fragile hands should hold the inhaler with both hands; for this, they will place the two index fingers on the top of the inhaler and the two thumbs on the base, below the mouthpiece.

If your doctor has given you different instructions for using the inhaler, follow them carefully. Inform your doctor if you have any difficulties.

Cleaning:

Clean the inhaler at least once a week.

1. Remove the mouthpiece protector.
2. Do not remove the cartridge from the plastic casing.
3. Clean the mouthpiece and the plastic casing inside and outside with a dry cloth, a paper tissue, or a small piece of cotton.
4. Replace the mouthpiece protector.

DO NOT SUBMERGE THE METAL CONTAINER IN WATER.

Consult your doctor or pharmacist if you have any doubts.

If you use more Inaspir than you should

If you have used Inaspir more than you should, you may notice that your heart beats faster than usual, headache, tremors, increased blood pressure, low potassium levels in the blood, feeling agitated and/or dizziness. Consult your doctor or pharmacist immediately or the Toxicological Information Service, phone: 91 562 04 20. If the dose taken was very high, go to your doctor immediately or to the nearest hospital emergency room. Bring this leaflet or the medication with you.

If you forgot to use Inaspir

If you forget to take a dose, do not worry. Inhale a dose when you remember and then continue as before.

Do not take a double dose to compensate for the missed doses.

If you have any other doubts about the use of this product, ask your doctor or pharmacist.

Like all medications, this medication may cause side effects, although not everyone will experience them.

Some people may be allergic to medications. If you experience any of the following symptoms shortly after using Inaspir, STOP taking this medication and inform your doctor immediately:

• Sudden onset of wheezing or chest tightness.
• Swelling of eyelids, face, or lips.
• Rash or urticaria on any part of the body.

Some people, particularly those taking high doses of this type of medication, may occasionally feel a bit agitated, experience headaches, or notice that their heart beats a bit faster than normal, but these effects usually subside as treatment continues. If this sensation persists, inform your doctor, but do not stop treatment unless they instruct you to.

The following side effects are associated with salmeterol. Inform your doctor if you experience any of the following symptoms:

Frequent side effects (may affect up to 1 in 10 people)

• Shakiness and headache. These are characteristics of this type of medication and usually subside over time. Shakiness is more frequent if you receive doses exceeding 50 micrograms, twice a day.
• Palpitations, which usually subside over time.
• Muscle cramps.

Possible side effects (may affect up to 1 in 100 people)

• Skin rash due to hypersensitivity reactions.
• Nervousness.
• Tachycardia (more frequent if you receive doses exceeding 50 micrograms, twice a day).

Rare side effects (may affect up to 1 in 1,000 people)

• Hypokalemia (low potassium levels in the blood).
• Insomnia.
• Dizziness.

Very rare side effects (may affect up to 1 in 10,000 people)

• Hypersensitivity reactions, including edema and angioedema (skin reaction with redness, swelling, itching, and difficulty breathing), bronchospasm (constriction of the bronchi causing difficulty breathing), and anaphylactic shock (severe allergic reaction).
• Hyperglycemia (elevated glucose levels in the blood). If you have diabetes, you may need to monitor your blood sugar levels more frequently and possibly adjust your diabetes treatment.
• Cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, and extrasystoles (heart rhythm disorders).
• Pharyngitis or laryngitis, paradoxical bronchospasm (narrowing of the bronchi with decreased airflow and difficulty breathing).
• Nausea.
• Arthralgia (joint pain).
• Non-specific chest pain.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

Place the mouthpiece cover firmly and close it with a snap to ensure the cap is in place.

Keep this medication out of sight and reach of children.

Do not store at a temperature above30ºC. Do not freeze.

Store in the original packaging to protect it from direct sunlight.

If the inhaler is very cold, remove the cartridge andwarm with your handfor a few minutes before use.Do not use any other method to warm it.

The cartridge contains a pressurized liquid. Do not expose to temperatures above 50ºC. Do not pierce, break, or burn the cartridge even if it is empty.

Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of through drains or in the trash. Dispose of the packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.

Composition of Inaspir

• The active ingredient is 25 micrograms of salmeterol (as xinafoate) per application.
• The other component is norflurano (HFA 134a).

This medication contains fluorinated greenhouse gases.

Each inhaler contains 12 g of HFC-134a (also known as norflurano or HFA 134a) corresponding to 0.0172 tons of CO2equivalent (global warming potential PCG = 1 430).

Appearance of the product and contents of the packaging

Inaspir is a pressurized inhalation suspension. Each inhaler provides 120 applications.

Holder of the marketing authorization and responsible manufacturer

Holder of the marketing authorization:

GlaxoSmithKline, S.A.

P.T.M. C/ Severo Ochoa, 2

28760 Tres Cantos (Madrid)

Tel: +34 900 202 700

[email protected]

Responsible manufacturer:

Glaxo Wellcome Productions, S.A.S

23, Rue Lavoisier - Zone Industrielle Nº 2 (Evreux La Madeleine) - F-27000 - France

or

Glaxo Wellcome, S.A.

Avda. de Extremadura, 3

Aranda de Duero (Burgos) - Spain.

Last review date of this leaflet:01/2025

The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/